机械通气患者镇静实践与临床结局:一项前瞻性多中心队列研究
本研究在秘鲁利马4家公立医院的5个ICU前瞻性纵向观察1657例机械通气危重患者,每日评估镇静状态至28天并随访90天生存。排除无RASS评分或无镇静数据者后,1338例(81%)纳入分析,共18645个ICU日。98%的患者在研究期间某一时点出现深镇静,深镇静与死亡率升高(OR=5.42,95%CI 4.23-6.95,P<0.001)及呼吸机、ICU、住院自由日减少相关;躁动亦与死亡率升高相关(OR=39.9,95%CI 6.53-243,P<0.001);苯二氮䓬类累积剂量较高者死亡率升高41%(OR=1.41,95%CI 1.12-1.77,P<0.01);氟哌啶醇使用与死亡率降低70%相关(OR=0.3,95%CI 0.22-0.44,P<0.001)。
要点
- 深镇静在研究期间任一时刻出现于98%的患者,并与90天死亡率升高独立相关(OR=5.42,95%CI 4.23-6.95,P<0.001)。
- 深镇静与呼吸机自由日(-7.27)、ICU自由日(-4.38)和住院自由日(-7.00)显著减少相关(P均<0.001)。
- 躁动与90天死亡率升高相关(OR=39.9,95%CI 6.53-243,P<0.001)。
- 苯二氮䓬类累积剂量较高(第75百分位 vs 第25百分位)与死亡率升高41%相关(OR=1.41,95%CI 1.12-1.77,P<0.01)。
- 氟哌啶醇仅用于3%的ICU日,但其使用与死亡率降低70%相关(OR=0.3,95%CI 0.22-0.44,P<0.001)。
适用人群与场景
- 在秘鲁利马4家公立医院的5个ICU中,对1657例机械通气危重患者进行每日镇静状态评估(持续28天)并随访90天生存。
- 最终纳入1338例(81%)有Richmond躁动-镇静量表(RASS)评分且接受镇静的患者进行纵向分析,共18645个ICU日。
诊断标准与关键阈值
- 使用Richmond躁动-镇静量表(RASS)评估镇静状态;无RASS评分或无镇静数据的患者被排除。
红旗征与不能漏的情况
- 深镇静:研究期间98%的患者出现,与死亡率升高独立相关(OR=5.42,95%CI 4.23-6.95,P<0.001)。
- 躁动:与死亡率升高相关(OR=39.9,95%CI 6.53-243,P<0.001)。
研究设计与关键结果
- 研究设计:前瞻性纵向多中心队列研究,在秘鲁利马4家公立医院的5个ICU进行。
- 样本量:共评估1657例,最终纳入1338例(81%)进行分析,累计18645个ICU日。
- 主要终点:深镇静与90天死亡率升高独立相关(OR=5.42,95%CI 4.23-6.95,P<0.001);躁动亦与死亡率升高相关(OR=39.9,95%CI 6.53-243,P<0.001)。
- 次要终点:深镇静与呼吸机自由日减少(-7.27,P<0.001)、ICU自由日减少(-4.38,P<0.001)和住院自由日减少(-7.00,P<0.001)相关。
- 药物使用:最常用镇静药为阿片类和苯二氮䓬类(分别为9259和8453个患者日);苯二氮䓬类累积剂量较高(第75百分位 vs 第25百分位)与死亡率升高41%相关(OR=1.41,95%CI 1.12-1.77,P<0.01);氟哌啶醇仅用于3%的ICU日,其使用与死亡率降低70%相关(OR=0.3,95%CI 0.22-0.44,P<0.001)。
- 累积剂量:第7天和第28天时苯二氮䓬类和阿片类的总体累积剂量分别高达774.5 mg和16.8 g;至第28天时这些剂量约翻倍。
证据类型、等级与局限
- 证据类型:前瞻性多中心纵向队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,深镇静、躁动和苯二氮䓬类累积剂量均与90天死亡率升高独立相关;深镇静还与呼吸机、ICU和住院自由日减少相关;氟哌啶醇在本研究中与死亡率降低相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We sought to study the association between sedation status, medications (benzodiazepines, opioids, and antipsychotics), and clinical outcomes in a resource-limited setting.
DESIGN: A longitudinal study of critically ill participants on mechanical ventilation.
SETTING: Five intensive care units (ICUs) in four public hospitals in Lima, Peru.
PATIENTS: One thousand six hundred fifty-seven critically ill participants were assessed daily for sedation status during 28 days and vital status by day 90.
RESULTS: After excluding data of participants without a Richmond Agitation Sedation Scale score and without sedation, we followed 1338 (81%) participants longitudinally for 18,645 ICU days. Deep sedation was present in 98% of participants at some point of the study and in 12,942 ICU days. Deep sedation was associated with higher mortality (interquartile odds ratio (OR) = 5.42, 4.23-6.95; p < 0.001) and a significant decrease in ventilator (- 7.27; p < 0.001), ICU (- 4.38; p < 0.001), and hospital (- 7.00; p < 0.001) free days. Agitation was also associated with higher mortality (OR = 39.9, 6.53-243, p < 0.001). The most commonly used sedatives were opioids and benzodiazepines (9259 and 8453 patient days respectively), and the latter were associated with a 41% higher mortality in participants with a higher cumulative dose (75th vs 25th percentile, interquartile OR = 1.41, 1.12-1.77; p < 0.01). The overall cumulative dose of benzodiazepines and opioids was high, 774.5 mg and 16.8 g, respectively, by day 7 and by day 28; these doses approximately doubled. Haloperidol was only used in 3% of ICU days; however, the use of it was associated with a 70% lower mortality (interquartile OR = 0.3, 0.22-0.44, p < 0.001).
CONCLUSIONS: Deep sedation, agitation, and cumulative dose of benzodiazepines were all independently associated with higher 90-day mortality. Additionally, deep sedation was associated with less ventilator-, ICU-, and hospital-free days. In contrast, haloperidol was associated with lower mortality in our study.
参考来源
- Aragón RE, Proaño A, Mongilardi N, et al. Sedation practices and clinical outcomes in mechanically ventilated patients in a prospective multicenter cohort. Crit Care. 2019. PMID: 30995940. doi:10.1186/s13054-019-2394-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。